| GTO ID | GTC1647 |
| Trial ID | NCT02919046 |
| Disease | Neuroblastoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Recruitment status | Unknown |
| Title | Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children |
| Year | 2016 |
| Country | China |
| Company sponsor | Sinobioway Cell Therapy Co., Ltd. |
| Other ID(s) | WM-CART-07 |
| Cohort 1 | |||||||
|
|||||||